The global continuous glucose monitoring device market size is expected to reach around US$ 10.6 billion by 2030 from US$ 4.7 billion in 2021 and is expected to grow at an impressive double-digit rate of 9.2% from 2021 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global continuous glucose monitoring device market for the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.
The increasing awareness regarding the diabetes coupled with the growing prevalence of diabetes among the population is driving the growth of the continuous blood glucose monitoring device market. According to the International Diabetes Federation, around 700 million people will have diabetes around the globe, by 2045. The alarming rise in the number of overweight and obese people across the globe is expected to fuel the demand for the CGM device, as obesity and overweight are the major causes of diabetes.
According to the World Health Organization, more than 1.9 billion global population were overweight, out of which around 650 million adults were obese in 2016. The unhealthy food habits, lack of proper diet, busy and hectic schedules of the people, and lack of physical activities are the major contributors of the growing diabetic population. Moreover, the rising geriatric population is also a significant factor that contributes to the growth of the CGM device market. Old age population is prone to high blood glucose levels and diabetes.
We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1374
North America dominated the global CGM device market, accounting for around 40% of the market share in 2020. North America is characterized by growing geriatric population, increased prevalence of diabetes, increased awareness regarding the CGM devices, increased consumer spending on the healthcare, and higher disposable income. All these factors positively contributes towards the growth of the CGM device market in the region. Furthermore, the presence of several prominent market players and various developmental strategies adopted by them has high influence on the market and the rising research and developmental activities adopted by them are expected to positively drive the market growth.
On the other hand, Asia Pacific is estimated to be the most opportunistic market during the forecast period. Asia Pacific is home to the huge population, characterized by rising awareness regarding diabetes, increasing awareness regarding the availability of CGM devices, and rising consumer expenditure on healthcare. Moreover, the rising penetration of diagnostic labs in the region is expected to augment demand for the CGM device during the forecast period. Countries like China, India, South Korea, and Indonesia are attracting FDIs in the healthcare sector owing to the favorable government policies, which is expected to dr4ive the growth of the CGM device market in the region.
Increased investments in the marketing of the CGM devices by the prominent market players significantly driven the demand for the CGM device among the population. The technological advancements in the CGM device like the introduction of improved sensors is further fueling the market demand across the globe.
The lack of awareness regarding the diabetes, increased illiteracy rate, and low income in the developing and the underdeveloped economies are the major restraining factors that may hinder the market growth in the forthcoming years.
The rising penetration of clinics, and diagnostic laboratories is expected to foster the demand for the CGM device in the forthcoming future. The rising disposable income and growing health consciousness will play a crucial role in the development of the CGM device market.
Based on the component, the sensors segment dominated the market, accounting for around 40% of the market share. The rapid adoption and extensive usage of sensor in the CGM has augmented the demand for the sensors across the globe. The sensors are considered accurate and effective in analyzing the blood glucose levels and hence its demand is high. With the advancements in the technologies, the efficiency of the sensors increased along with the increased affordability. The rising affordability will propel the demand for the CGM devices in the low and middle income countries.
Based on the end user, the home healthcare segment garnered a market share of around 42%, leading the global market. The easy availability of numerous CGM devices across the globe has fostered the growth of this segment. Further, the increased prevalence of diabetes and rising awareness among the population regarding the diabetes control and preventive measures has significantly contributed towards the growth of this segment.
Why should you invest in this report?
If you are aiming to enter the global continuous glucose monitoring device market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for continuous glucose monitoring device are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global continuous glucose monitoring device market include:
- Abbott Laboratories
- Dexcom, Inc.
- A. Menarini Diagnostics
- Echo Therapeutics, Inc.
- GlySens Incorporated
- Johnson & Johnson
- Medtronic plc
- Senseonics Holdings, Inc.
- F. Hoffmann-La Roche Ltd
- Ypsomed
Market Segmentation:
By Component
- Transmitters
- Receivers
- Sensors
- Integrated Insulin Pumps
By End User
- Hospitals
- Home Healthcare
- Others
Regional Analysis:
The geographical analysis of the global continuous glucose monitoring device market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global continuous glucose monitoring device Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global continuous glucose monitoring device market in 2030?
- What is the expected CAGR for the continuous glucose monitoring device market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global continuous glucose monitoring device market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Continuous Glucose Monitoring (CGM) Device Market
5.1. COVID-19 Landscape: Continuous Glucose Monitoring (CGM) Device Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Continuous Glucose Monitoring (CGM) Device Market, By Component
8.1. Continuous Glucose Monitoring (CGM) Device Market, by Component Type, 2021-2030
8.1.1. Transmitters
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Receivers
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Sensors
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Integrated Insulin Pumps
8.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Continuous Glucose Monitoring (CGM) Device Market, By End User
9.1. Continuous Glucose Monitoring (CGM) Device Market, by End User, 2021-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Home Healthcare
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Continuous Glucose Monitoring (CGM) Device Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Component (2019-2030)
10.1.2. Market Revenue and Forecast, by End User (2019-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Component (2019-2030)
10.1.3.2. Market Revenue and Forecast, by End User (2019-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Component (2019-2030)
10.1.4.2. Market Revenue and Forecast, by End User (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Component (2019-2030)
10.2.2. Market Revenue and Forecast, by End User (2019-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Component (2019-2030)
10.2.3.2. Market Revenue and Forecast, by End User (2019-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Component (2019-2030)
10.2.4.2. Market Revenue and Forecast, by End User (2019-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Component (2019-2030)
10.2.5.2. Market Revenue and Forecast, by End User (2019-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Component (2019-2030)
10.2.6.2. Market Revenue and Forecast, by End User (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Component (2019-2030)
10.3.2. Market Revenue and Forecast, by End User (2019-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Component (2019-2030)
10.3.3.2. Market Revenue and Forecast, by End User (2019-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Component (2019-2030)
10.3.4.2. Market Revenue and Forecast, by End User (2019-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Component (2019-2030)
10.3.5.2. Market Revenue and Forecast, by End User (2019-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Component (2019-2030)
10.3.6.2. Market Revenue and Forecast, by End User (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Component (2019-2030)
10.4.2. Market Revenue and Forecast, by End User (2019-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Component (2019-2030)
10.4.3.2. Market Revenue and Forecast, by End User (2019-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Component (2019-2030)
10.4.4.2. Market Revenue and Forecast, by End User (2019-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Component (2019-2030)
10.4.5.2. Market Revenue and Forecast, by End User (2019-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Component (2019-2030)
10.4.6.2. Market Revenue and Forecast, by End User (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Component (2019-2030)
10.5.2. Market Revenue and Forecast, by End User (2019-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Component (2019-2030)
10.5.3.2. Market Revenue and Forecast, by End User (2019-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Component (2019-2030)
10.5.4.2. Market Revenue and Forecast, by End User (2019-2030)
Chapter 11. Company Profiles
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Dexcom, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. A. Menarini Diagnostics
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Echo Therapeutics, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. GlySens Incorporated
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Johnson & Johnson
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Medtronic plc
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Senseonics Holdings, Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. F. Hoffmann-La Roche Ltd
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Ypsomed
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1374
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
0 Comments